Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,847 GBX | +0.11% |
|
-3.08% | +3.86% |
Jun. 24 | Teva launches generic version of Novo Nordisk's diabetes drug Victoza | RE |
Jun. 20 | Fitch Confirms Ratings, Outlook on Hikma Pharmaceuticals on 'Defensive Market Position' | MT |
Financials (USD)
Sales 2024 * | 2.99B | Sales 2025 * | 3.09B | Capitalization | 5.19B |
---|---|---|---|---|---|
Net income 2024 * | 413M | Net income 2025 * | 450M | EV / Sales 2024 * | 2.02 x |
Net Debt 2024 * | 859M | Net Debt 2025 * | 612M | EV / Sales 2025 * | 1.88 x |
P/E ratio 2024 * |
12.8
x | P/E ratio 2025 * |
11.7
x | Employees | 9,100 |
Yield 2024 * |
3.05% | Yield 2025 * |
3.23% | Free-Float | 65.63% |
Latest transcript on Hikma Pharmaceuticals PLC
1 day | +0.16% | ||
1 week | -3.08% | ||
Current month | -1.75% | ||
1 month | -5.16% | ||
3 months | -0.59% | ||
6 months | +2.43% | ||
Current year | +3.86% |
![Extreme 1829](/images/extremecours_fleche.png)
![Extreme 1829](/images/extremecours_fleche.png)
![Extreme 1750](/images/extremecours_fleche.png)
![Extreme 1711](/images/extremecours_fleche.png)
![Extreme 1174.5](/images/extremecours_fleche.png)
![Extreme 1174.5](/images/extremecours_fleche.png)
![Extreme 814.2](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Riad Mishlawi
CEO | Chief Executive Officer | 60 | 89-12-31 |
Khalid Nabilsi
DFI | Director of Finance/CFO | 52 | 00-12-31 |
Said Darwazah
CHM | Chairman | 67 | 80-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Hurt
BRD | Director/Board Member | 67 | 20-04-30 |
Nina Henderson
BRD | Director/Board Member | 73 | 16-09-30 |
Victoria Hull
BRD | Director/Board Member | 62 | 22-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 1,056 M€ | +1.13% | ||
0.25% | 3 M€ | +9.95% | - | |
0.20% | 11 M€ | +0.83% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-03 | 1,858 | +0.70% | 4 548 |
24-07-02 | 1,845 | -1.18% | 454,028 |
24-07-01 | 1,867 | -1.27% | 429,135 |
24-06-28 | 1,891 | +0.85% | 414,106 |
24-06-27 | 1,875 | -2.19% | 440,341 |
Delayed Quote London S.E., July 03, 2024 at 03:18 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.86% | 5.19B | |
+55.55% | 816B | |
+41.53% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+13.91% | 238B | |
+1.06% | 222B | |
+13.37% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- HIK Stock